ATE192454T1 - Verfahren zur herstellung von (11beta,16beta)-21- (3-carboxy-3-oxopropoxy)-11-hydroxy-2'-methyl-5 h-pregna-1,4-dieno(17,16-d)oxazole-3,20-dione - Google Patents

Verfahren zur herstellung von (11beta,16beta)-21- (3-carboxy-3-oxopropoxy)-11-hydroxy-2'-methyl-5 h-pregna-1,4-dieno(17,16-d)oxazole-3,20-dione

Info

Publication number
ATE192454T1
ATE192454T1 AT96942324T AT96942324T ATE192454T1 AT E192454 T1 ATE192454 T1 AT E192454T1 AT 96942324 T AT96942324 T AT 96942324T AT 96942324 T AT96942324 T AT 96942324T AT E192454 T1 ATE192454 T1 AT E192454T1
Authority
AT
Austria
Prior art keywords
16beta
dieno
11beta
pregna
oxazole
Prior art date
Application number
AT96942324T
Other languages
English (en)
Inventor
Luigi Forte
Calogero Cancellieri
Original Assignee
Lepetit Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lepetit Spa filed Critical Lepetit Spa
Application granted granted Critical
Publication of ATE192454T1 publication Critical patent/ATE192454T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J71/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J71/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0036Nitrogen-containing hetero ring
    • C07J71/0057Nitrogen and oxygen
    • C07J71/0068Nitrogen and oxygen at position 16(17)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Steroid Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT96942324T 1995-12-13 1996-12-04 Verfahren zur herstellung von (11beta,16beta)-21- (3-carboxy-3-oxopropoxy)-11-hydroxy-2'-methyl-5 h-pregna-1,4-dieno(17,16-d)oxazole-3,20-dione ATE192454T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP95119627 1995-12-13
PCT/EP1996/005391 WO1997021723A1 (en) 1995-12-13 1996-12-04 PREPARATION OF (11β,16β)-21-(3-CARBOXY-3-OXOPROPOXY)-11-HYDROXY-2'-METHYL-5'H-PREGNA-1,4-DIENO[17,16-D]OXAZOLE-3,20-DIONE

Publications (1)

Publication Number Publication Date
ATE192454T1 true ATE192454T1 (de) 2000-05-15

Family

ID=8219883

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96942324T ATE192454T1 (de) 1995-12-13 1996-12-04 Verfahren zur herstellung von (11beta,16beta)-21- (3-carboxy-3-oxopropoxy)-11-hydroxy-2'-methyl-5 h-pregna-1,4-dieno(17,16-d)oxazole-3,20-dione

Country Status (20)

Country Link
US (1) US6417350B1 (de)
EP (1) EP0879242B1 (de)
JP (1) JP4076097B2 (de)
KR (1) KR100433566B1 (de)
CN (1) CN100351266C (de)
AT (1) ATE192454T1 (de)
AU (1) AU707406B2 (de)
CA (1) CA2238692C (de)
DE (1) DE69608134T2 (de)
EA (1) EA000731B1 (de)
ES (1) ES2145507T3 (de)
GR (1) GR3033940T3 (de)
HU (1) HU226668B1 (de)
MX (1) MX9804574A (de)
NO (1) NO309094B1 (de)
NZ (1) NZ324299A (de)
PT (1) PT879242E (de)
SI (1) SI0879242T1 (de)
WO (1) WO1997021723A1 (de)
ZA (1) ZA9610413B (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0876394T3 (da) * 1995-12-13 2001-08-06 Lepetit Spa Fremstilling af (11beta, 16beta)-21-(acetyloxy)-11-hydroxy-2'-methyl-5'H-pregna-1,4-dieno[17,16-d]oxazol-3,20-dion

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1141930B (it) * 1980-04-28 1986-10-08 Lepetit Spa Esteri idrosolubili di steroido-ossazoli e loro composizioni farmaceutiche
GB8730216D0 (en) * 1987-12-29 1988-02-03 Lepetit Spa Process for preparation of pregnenooxazolines
CN1092066A (zh) * 1993-03-04 1994-09-14 商业部科学研究院 6-甲基-1,2,3-噁噻嗪-4(3h)-酮-2,2-二氧化物及其盐的合成方法
DK0876394T3 (da) * 1995-12-13 2001-08-06 Lepetit Spa Fremstilling af (11beta, 16beta)-21-(acetyloxy)-11-hydroxy-2'-methyl-5'H-pregna-1,4-dieno[17,16-d]oxazol-3,20-dion

Also Published As

Publication number Publication date
HUP9903535A3 (en) 2000-04-28
KR19990072025A (ko) 1999-09-27
HU226668B1 (en) 2009-06-29
AU707406B2 (en) 1999-07-08
DE69608134T2 (de) 2001-01-11
CN100351266C (zh) 2007-11-28
KR100433566B1 (ko) 2004-07-16
EA000731B1 (ru) 2000-02-28
NZ324299A (en) 1999-04-29
NO982413L (no) 1998-05-27
JP2000503633A (ja) 2000-03-28
MX9804574A (es) 1998-09-30
GR3033940T3 (en) 2000-11-30
HK1017690A1 (en) 1999-11-26
DE69608134D1 (de) 2000-06-08
AU1175797A (en) 1997-07-03
PT879242E (pt) 2000-10-31
WO1997021723A1 (en) 1997-06-19
EA199800551A1 (ru) 1998-12-24
ES2145507T3 (es) 2000-07-01
US6417350B1 (en) 2002-07-09
CA2238692C (en) 2004-07-20
CA2238692A1 (en) 1997-06-19
EP0879242B1 (de) 2000-05-03
SI0879242T1 (en) 2000-08-31
NO982413D0 (no) 1998-05-27
CN1204340A (zh) 1999-01-06
EP0879242A1 (de) 1998-11-25
ZA9610413B (en) 1997-09-09
NO309094B1 (no) 2000-12-11
HUP9903535A2 (hu) 2000-03-28
JP4076097B2 (ja) 2008-04-16

Similar Documents

Publication Publication Date Title
DE69619030D1 (de) Verfahren zur Herstellung von Essigsäure durch Carbonylierung
ATE89315T1 (de) Faktor viii-analog, verfahren zu dessen herstellung und dieses enthaltende zusammensetzung.
DE19681532T1 (de) Verfahren zur Herstellung von L-Glutaminsäure durch Fermentation
DE50214951D1 (de) Verfahren zur herstellung von 2-halogenacyl-3-amino-acrylsäure- derivaten
ATE227579T1 (de) Verfahren zur herstellung von makrophagen und ausrüstungen zur durchführung dieses verfahrens
DE69011880D1 (de) Verfahren zur Herstellung von L-Aminosäuren durch Fermentation.
ATE144526T1 (de) Neues verfahren zur herstellung 11-keto steroidderivate
DE69415345D1 (de) Verfahren zur herstellung von bisnoraldehyden aus bisnoralkohol
DE60120352D1 (de) Verfahren zur industriellen herstellung von betulinsäuren
ATE159259T1 (de) Verfahren zur herstellung taurin-konjugierter gallensäure
ATE192454T1 (de) Verfahren zur herstellung von (11beta,16beta)-21- (3-carboxy-3-oxopropoxy)-11-hydroxy-2'-methyl-5 h-pregna-1,4-dieno(17,16-d)oxazole-3,20-dione
DE59611019D1 (de) Verfahren zur Herstellung von Hydrazincarbonsäureestern und Zwischenprodukte dieses Verfahrens
ATE1142T1 (de) Verfahren zur herstellung von methylen-bis-(4-phenyl-carbaminsaeureester).
ATE36519T1 (de) Verfahren zur herstellung von alpha,beta|thylenisch ungesaettigten estern.
ATE146166T1 (de) Verfahren zur herstellung von 2,2,-dimethyl-3- ((z)-2- (alkoxycarbonyl)ethenyl)cyclopropancarbonsäuree tern und zwischenprodukte
DE69612871D1 (de) Verfahren zur herstellung von (11beta,16beta)-21-(acetyloxy)-11-hydroxy-2'-methyl-5'h-pregna-1,4-dieno(17,16-d)oxazole-3,20-dione
ATE26840T1 (de) Verfahren zur herstellung von delta 5,7 steroiden.
DE69507139D1 (de) Verfahren zur herstellung von 4-amino-delta 4-3-ketosteroiden via 4-nitro-delta-4-3-ketosteroiden
AU567934B2 (en) Preparation 21-hydroxy-20-keto-delta 16 steroids and intermediates
ATE163181T1 (de) Verfahren zur herstellung von 2- cyaniminothiazolidin
ATE10623T1 (de) Verfahren zur herstellung von l-prolin.
ATE161260T1 (de) Verfahren zur herstellung von beta- aminoalkylborsäure und deren estern
DE59906968D1 (de) Verfahren zur herstellung von 1-alkyl-pyrazol-5-carbonsäureestern
DE69116198D1 (de) Verfahren zur Herstellung von D-Isocitronensäure durch Fermentation
DE3887070D1 (de) Verfahren zur Herstellung von Brenztraubensäure durch Fermentation.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EEIH Change in the person of patent owner
EEIH Change in the person of patent owner